Randomized, Multicenter, Open-Label Phase II Study of Gemcitabine plus Single-Dose Versus Split-Dose Carboplatin in the Treatment of Patients with Advanced-Stage Non-Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

Randomized, Multicenter, Open-Label Phase II Study of Gemcitabine plus Single-Dose Versus Split-Dose Carboplatin in the Treatment of Patients with Advanced-Stage Non-Small-Cell Lung Cancer

Published:2006-09 Issue:2 Volume:8 Page:135-139
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Schuette Wolfgang,Blankenburg Thomas,Schneider Claus-Peter,von Weikersthal Ludwig Fischer,Guetz Sylvia,Laier-Groeneveld Gerhard,Christian Virchow Johann,Chemaissani Assnad,Reck Martin

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference24 articles.

1. Single agent versus combination chemotherapy in patients with advanced nonsmall cell lung carcinoma: a meta-analysis of response, toxicity, and survival;Lilenbaum;Cancer,1998

2. A systematic overview of chemotherapy effects in non-small cell lung cancer. Swedish Council of Technology Assessment in Health Care;Sörenson;Acta Oncol,2001

3. Addition of platinum compounds to a new agent in patients with advanced non-small-cell lung cancer: a literature based meta-analysis of randomised trials;Hotta;Ann Oncol,2004

4. Platinum-based versus non-platinumbased chemotherapy in advanced non-small-cell lung cancer: a meta-analysis of the published literature;D'Addario;J Clin Oncol,2005

5. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003;Pfister;J Clin Oncol,2004

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of contemporary platinum-doublet chemotherapy-modified dose and schedules;Lung Cancer Management;2013-10

2. Comparison of Hematotoxicity between Gemcitabine-cisplatin Therapy and Gemcitabine-carboplatin Therapy for Urothelial Cancer;Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences);2013

3. A Phase II Study of First-Line Chemotherapy with Weekly Carboplatin Plus Gemcitabine in Advanced Non-Small Cell Lung Cancer;Chemotherapy;2012

4. Gemcitabine and carboplatin in combination for the treatment of advanced, metastatic, non-small cell lung cancer;Expert Opinion on Pharmacotherapy;2007-11-26